Trailing-twelve-month (TTM) revenue is $6.90 Billion with a year-over-year growth of +12.18%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,640,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $1,692,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $1,744,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $1,825,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $6,902,500,000 |
Current P/S: $13,635,815,720 market capitalization ÷ $6,902,500,000 TTM revenue = 1.98x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T19:50:08.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.83B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T19:50:47.275Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Distribution and Shareholder Service | $1.4B | $1.6B | $1.4B | $1.4B | $1.5B | $1.5B |
| Financial Service, Other | $210M | $246M | $217M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $4.5B | $5.2B | $4.7B | $4.4B | $4.7B | $4.8B |
| Asia | $326M | $349M | $285M | $264M |
$6.90B
$6.90 Billion
+12.18%
vs. $6.15B a year ago (TTM)
+1.18%
5 Year compound annual growth rate
1 Year
+12.18%
3 Year
+6.28%
5 Year
+1.18%
10 Year
+3.59%
15 Year
+3.57%
20 Year
+5.60%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $6.38B | +$310.10M | +5.11% |
| 2024 | $6.07B | +$350.60M | +6.13% |
| 2023 | $5.72B | ($332.50M) | (5.50%) |
| 2022 | $6.05B | ($845.60M) | (12.26%) |
| 2021 | $6.89B | +$748.90M | +12.19% |
| 2020 |
TTM Growth
+12.18%
3-Year CAGR
+6.28%
5-Year CAGR
+1.18%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $199M |
| $202M |
| Investment Advice | $4.5B | $5.0B | $4.4B | $4.1B | $4.3B | $4.6B |
|---|
| Investment Performance | $66M | $56M | $68M | $47M | $46M | $42M |
|---|
| $295M |
| EMEA, Excluding United Kingdom | $645M | $725M | $1.1B | $1.1B | $1.1B | $1.3B |
|---|
| UNITED KINGDOM | $633M | $646M | N/A | N/A | N/A | N/A |
|---|
| $6.15B |
| +$28.20M |
| +0.46% |
| 2019 | $6.12B | +$803.30M | +15.12% |
| 2018 | $5.31B | +$153.80M | +2.98% |
| 2017 | $5.16B | +$425.90M | +9.00% |
| 2016 | $4.73B | ($388.50M) | (7.58%) |
